$TLSA

$1.08▲ +2.9% YTD

3 SEC 13D/G filings tracked · Last updated Oct 16, 2026

Filing History

News

TLSA ▲ +2.9% - Tiziana Life Sciences Ltd

CP $1.08▲ +2.9%Oct 16, 2026 · ThinkSabio Blog

$TLSA - Tiziana Doses Last Patient in Phase 2 Trial of Intranasal Foralumab for Mild Alzheimer’s Disease…

News

TLSA ▲ +6.3% - Tiziana Life Sciences Ltd

CP $1.01▲ +6.3%Sep 30, 2026 · ThinkSabio Blog

$TLSA - Tiziana Life Sciences Files for Orphan Drug Designation with the FDA for Intranasal Foralumab for the Treatment of Multiple System Atrophy (MS…

News

TLSA ▼ -1.0% - Tiziana Life Sciences Ltd

CP $1.00▲ -1.0%Sep 28, 2026 · ThinkSabio Blog

$TLSA - Tiziana Life Sciences Announces First Participants Dosed in ALS BANYAN Clinical Trial of Intranasal Foralumab…